EUVIMEDEUVIMED entdecken
Crossref

Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk

Ahmet Ziya Şahin, Orhan Özdemir, Özlem Usalan, Fatih Mehmet Erdur, Celalettin Usalan

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.02.067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Ahmet Ziya Şahin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Gaziantep University School of Medicine, Gaziantep, Turkey. Electronic address: drahmetziya@hotmail.com. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Renal Insufficiency, Chronic. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Advances in immunosuppressive therapies and surgical techniques have led to a significant reduction in the incidence of rejection within 1 year after kidney transplantation. Immunologic risk is an important factor affecting graft functions and guiding the clinician in the selection of induction therapy. The aim of this study was to investigate graft functions based on serum creatinine levels, Chronic Kidney Disease Epidemiology Collaboration (CKD- EPI) and proteinuria levels, frequency of leukopenia, cytomegalovirus (CMV) and BK virus polymerase chain reaction (PCR) positivity in patients with low and high immunologic risk. MATERIAL AND METHODS: This retrospective study included 80 renal recipients. Recipients were divided into 2 groups: patients at low immunologic risk who received basiliximab only and those with high immunologic risk who received low-dose (1.5 mg/kg for 3 days) antithymocyte globulin and basiliximab. RESULTS: No significant differences were observed between the 2 risk groups in terms of first, third, sixth, and 12th-month creatinine levels, CKD-EPI, proteinuria levels, leukopenia frequency, and CMV and BK virus PCR positivity. CONCLUSION: One-year graft survivals did not differ significantly between these 2 treatment modalities. The combined use of low-dose antithymocyte globulin and basiliximab in the induction treatment of patients with high immunologic risk seems promising in terms of graft survival, leukopenia frequency, and CMV and BK virus PCR positivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsRenal Insufficiency, ChronicHumansBasiliximabImmunosuppressive AgentsAntilymphocyte SerumAntibodies, MonoclonalRetrospective StudiesInduction ChemotherapyGraft RejectionGraft SurvivalProteinuriaRecombinant Fusion Proteins

Substanzen

BasiliximabImmunosuppressive AgentsAntilymphocyte SerumAntibodies, MonoclonalRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Nephrology, Gaziantep University School of Medicine, Gaziantep, Turkey. Electronic address: drahmetziya@hotmail.com.
  • Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey.
  • Department of Nephrology, Gaziantep University School of Medicine, Gaziantep, Turkey.

Zitieren

APA

Şahin, A. Z., Özdemir, O., Usalan, Ö., Erdur, F. M., & Usalan, C. (2023). Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.02.067

Vancouver

Şahin AZ, Özdemir O, Usalan Ö, Erdur FM, Usalan C. Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.02.067

BibTeX
@article{ahin2023,
  author = {Şahin, Ahmet Ziya and Özdemir, Orhan and Usalan, Özlem and Erdur, Fatih Mehmet and Usalan, Celalettin},
  title = {Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.02.067}
}
Kostenlos starten →